JDD Issue Highlights | February 2022
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ …
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ … 
The numbers are staggering when it comes to the management of skin cancer in the United States and worldwide. Signs of chronic exposure to ultraviolet (UV) rays from the sun and/or indoor tanning bed use include solar lentigines, hyperpigmentation, wrinkles and pre-cancerous lesions called actinic keratoses. Actinic Keratoses (AKs) best identified as scaly, pink macules and papules, result from lo … 
The Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights:
Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation.
… 
Pustular psoriasis can present quickly and pose a life-threatening emergency. Acitretin is the only systemic retinoid FDA-approved for treatment of psoriasis, specifically both pustular and severe plaque-type psoriasis.1Systemic retinoids such as acitretin are utilized heavily in dermatology, and practitioners must be knowledgeable about all of the FDA-approved and off-label applications as well a … 
Dr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference.
Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A …